v3.22.2
Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
6 Months Ended
Jun. 30, 2022
Jun. 30, 2021
Cash flows from operating activities    
Net loss $ (111,893) $ (106,511)
Reconciliation of net loss to net cash used in operating activities:    
Depreciation and amortization expense 11,073 7,295
Non-cash interest expense and amortization of debt costs 0 1,789
Stock-based compensation expense 38,862 11,800
Write-off of in-process research and development project 0 5,030
Other non-cash compensation expense 0 3,747
Gain from change in the fair value of warrants and earnout shares (59,512) 0
Income from equity method investment (19,039) (2,107)
Net accretion and amortization of investments in marketable debt securities 86 2,530
Changes in operating assets and liabilities    
Other receivables and prepaid expenses and other current assets 512 (2,734)
Other non-current assets 22,336 (124)
Accounts payable and accrued and other liabilities 3,064 1,752
Net cash used in operating activities (114,511) (77,533)
Cash flows from investing activities    
Purchase of marketable securities (867,257) (289,092)
Proceeds from sales of marketable securities 45,227 40,227
Proceeds from maturities of marketable securities 319,928 239,415
Purchases of property and equipment (19,032) (14,509)
Acquisition, net of cash (5,707) (4,981)
Net cash used in investing activities (526,841) (28,940)
Cash flows from financing activities    
Taxes paid related to net share settlement of equity awards (85) 0
Proceeds from issuance of convertible notes 0 74,972
Proceeds from the exercise of stock options and warrants issuance 744 672
Repayments of tenant improvement loan and capital lease obligation (577) (554)
Payments for deferred offering costs 0 (1,621)
Net cash provided by financing activities 82 73,469
Net change in cash, cash equivalents and restricted cash (641,270) (33,004)
Cash, cash equivalents and restricted cash, at the beginning of the period 956,325 78,030
Cash, cash equivalents and restricted cash, at the end of the period 315,055 45,026
Reconciliation of cash, cash equivalents and restricted cash to condensed consolidated balance sheets    
Cash and cash equivalents 311,089 44,264
Restricted cash 3,966 762
Cash, cash equivalents and restricted cash 315,055 45,026
Non-cash investing and financing activities    
Unpaid property and equipment purchases 236 1,011
Uber acquisition in exchange for Series C redeemable convertible preferred stock 0 77,619
Property and equipment purchased through capital leases $ 252 $ 926

Source